An interventional study of Food Assistance Program and Standard of Care in Treatment Adherence, sponsored by Virginia Commonwealth University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-15.
Sponsored by Virginia Commonwealth University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 75 studies in Treatment Adherence and Compliance with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Treatment Adherence and Compliance · United States.
Among the 75 studies in Treatment Adherence and Compliance with a site in United States, this one is the 6th largest by planned enrollment of the 70 interventional ones that give a count, is one of 5 that started in 2026, is one of 58 with no phase, reaches primary completion later than 14 of the 14 other live ones, and was the 72nd registered.
353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.
Browse Treatment Adherence and Compliance studies →12 of the 75 studies in Treatment Adherence and Compliance with a site in United States are open now. Recruiting first, the newest first:
Northwestern University · Sites in United States
Healthy volunteers
University of Maryland, Baltimore · Sites in United States
Ages 18–65
The University of Texas Health Science Center at San Antonio · Sites in United States
Ages 18+ · Women only
National Heart, Lung, and Blood Institute (NHLBI) · Sites in United States
Ages 18+
Lifespan · Sites in United States
Ages 18+ · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
75 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 8 · Phase 3 4 · Phase 4 1
First in 2003; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 350 is above the median of 83 across 273 interventional studies indexed under Treatment Adherence and Compliance.
Median enrollment 66 across the 70 interventional studies, 384 across the 5 observational. Of the 57 that completed or were terminated, 23 (40%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 75 have an industry lead sponsor. The 10 most frequent:
Virginia Commonwealth University is the lead sponsor of 648 studies on the registry; 79 are open to participants now.
Of its 90 completed or terminated interventional studies of FDA-regulated products, 64 (71%) have results posted.
Virginia Commonwealth University has 1 study filed under Treatment Adherence and Compliance — fewer than ten, so there is no comparison to draw.
7 of the studies in Treatment Adherence and Compliance with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05489068University of New MexicoMotivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment | 2026-12-01 |
| NCT07542769Northwestern UniversityChoice and Autonomy in Learning Mindfulness for Pediatric Residents | 2026-12-31 |
| NCT07881783Novartis PharmaceuticalsA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy | 2027-03-31 |
| NCT05973838University of Maryland, College ParkPeer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention | 2027-07-01 |
| NCT06909552University of Colorado, DenverUse of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction | 2027-07-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 75 studies in Treatment Adherence and Compliance with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective cohort and descriptive study aimed at identifying cancer patients experiencing food insecurity at Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center. The study will involve evaluating the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Six month food assistance program-shelf-stable food boxes
Other: Food Assistance Program
Usual-care referrals
Other: Standard of Care
Participants will be enrolled and provided with structured food assistance (e.g., shelf stable food boxes, produce vouchers) for six months
Also known as: Intervention Cohort
Participants who receive usual-care referrals but not food packages.
Also known as: Comparison Cohort
Evaluate the impact of a food assistance intervention on treatment adherence and clinical outcomes among food-insecure patients on active treatment.
Percent of participants that self-report of treatment completion
Time frame: 6 months following enrollment
Change in Food Insecurity Score
Using the Food Insecurity Assessment: a 2 Question Hunger Vital Signs will be used to assess patient food insecurity status with the following two questions: "Within the past 12 months, did you worry your food would run out before you got the money to buy more?" "Within the past 12 months, did the food you buy not last and you didn't have money to get more?" Scoring will categorize patients as never true, sometimes true, or often true. Baseline is defined as when a patient responds SOMETIMES TRUE or OFTEN TRUE to one of the two validated Hunger Vital Sign Screening questions for the first time. Patients will receive an email about the financial impact and QOL validated surveys at each time interval.
Time frame: Baseline and 6 month follow-up
Change in Quality of Life (QOL) using European Organisation for Research and Treatment of Cancer Core Quality of Life questionnaire (EORTC QLQ-30)
The EORTC QLQ-30 questionnaire is a 30-item, patient-reported instrument designed to assess the health-related quality of life (HRQoL), functional status, and symptom burden of cancer patients. Comprises 30 questions grouped into 5 functional scales, 9 symptom scales/items, and a global health status. Scoring: Uses a 4-point Likert scale (7-point for global items), transformed to a 0-100 scale. Higher scores indicate better function/QoL, but worse symptom burden.
Time frame: Baseline and 6 month follow-up
Change in financial toxicity
The Functional Assessment of Chronic Illness Therapy for measure of financial toxicity (FACIT-COST) questionnaire to assess the impact of treatment on patient financial status. This measure has 12 questions based on patient reported outcomes to assess financial quality of life stress; numeric responses 0-4; Uses a score range 0-44 with higher scores indicating better Financial Well-Being.
Time frame: Baseline and 6 month follow-up
Plan to share: No — There are no current plans to share individual patient data.
No publications or documents are linked to this record.
Started Jul 2026 (actual). Primary completion is estimated for Aug 2035, 109 months after the start.
Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's planned 109 months is above that.
Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Treatment Adherence and Compliance →
Virginia Commonwealth University →